Ozempic 0.25mg Injection

Ozempic 0.25 mg Injection – Semaglutide for Type 2 Diabetes Management

Ozempic 0.25 mg Injection is a prescription injectable medicine containing Semaglutide 0.25 mg per dose. It is used alongside diet and regular physical activity to improve blood-sugar control in adults with type 2 diabetes mellitus. Semaglutide belongs to a group of medicines known as glucagon-like peptide-1 receptor agonists, also called GLP-1 receptor agonists. It helps increase insulin release when blood sugar is elevated, reduces excess glucagon secretion, and slows gastric emptying. Ozempic 0.25 mg is generally used as the starting dose for the first four weeks to help the body adjust to treatment. It is not normally used as a long-term maintenance dose.

Key Features

• Contains Semaglutide: A once-weekly GLP-1 receptor agonist.
• 0.25 mg Per Dose: Each prescribed injection delivers 0.25 mg of semaglutide.
• Starting-Dose Strength: Generally used during the first four weeks of treatment.
• Supports Blood-Sugar Control: Helps reduce elevated glucose levels in adults with type 2 diabetes.
• Once-Weekly Administration: Designed for use on the same day each week.
• Pre-Filled Pen: Allows convenient subcutaneous administration.
• Four-Dose Presentation: The 0.25 mg pen provides four weekly doses and is supplied with four disposable needles.

Active Ingredient

• Semaglutide 0.25 mg per dose: A GLP-1 receptor agonist that supports glucose-dependent insulin release, reduces excess glucagon secretion, and slows stomach emptying.

Uses

• Improvement of blood-sugar control in adults with type 2 diabetes mellitus.
• Used alongside an appropriate diet and regular physical activity.
• May be prescribed alone when metformin is unsuitable.
• May be prescribed with other diabetes medicines when additional glucose control is required.
• Initial dose-escalation stage before moving to a higher prescribed semaglutide dose.

How to Use

• Do not inject it into a vein or muscle.
• Rotate the injection site with every weekly dose.
• Attach a new compatible disposable needle before every injection.
• Check the medicine flow before the first injection from each new pen.
• Turn the dose selector until the dose counter displays 0.25 mg.
• Press and hold the dose button until the dose counter returns to zero.
• Remove and safely discard the needle immediately after every injection.
• Never share the injection pen or needles with another person.

Missed Dose

• If five days or fewer have passed since the missed dose, inject it as soon as remembered.
• Take the next dose on the regularly scheduled weekly day.
• If more than five days have passed, skip the missed dose.
• Do not inject a double dose to compensate for a missed dose.

Precautions

• Ozempic 0.25 mg is a starting dose and should not be increased without medical advice.
• It is not intended for type 1 diabetes or diabetic ketoacidosis.
• Nausea, vomiting, and diarrhoea may cause dehydration and may affect kidney function.
• The risk of low blood sugar may increase when used with insulin or sulfonylurea medicines.
• Report sudden or worsening changes in vision promptly.
• Inform healthcare professionals that you use semaglutide before surgery, general anaesthesia, or deep sedation.
• Do not combine it with another semaglutide product or GLP-1 receptor agonist unless specifically prescribed.

Possible Side Effects

• Nausea.
• Vomiting.
• Diarrhoea.
• Constipation.
• Indigestion or acid reflux.
• Reduced appetite.
• Headache or dizziness.
• Fatigue.

Storage

• Before first use, store the pen in a refrigerator between 2°C and 8°C.
• Do not freeze or use a pen that has been frozen.
• Keep the pen cap attached to protect the medicine from light.
• During use, store below 30°C or in a refrigerator between 2°C and 8°C for up to six weeks.
• Do not store the pen with a needle attached.
• Keep out of the sight and reach of children.

Legal Disclaimer: Ozempic 0.25 mg Injection is a prescription semaglutide medicine intended for adults with type 2 diabetes. The 0.25 mg strength is generally an initial dose and is not intended as a long-term maintenance dose. Dose escalation, treatment duration, and combination with other diabetes medicines must be determined by a qualified healthcare professional. This information is provided for educational purposes and should not replace the official product instructions.